SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-004448
Filing Date
2015-03-10
Accepted
2015-03-10 18:10:24
Documents
1
Period of Report
2015-03-07

Document Format Files

Seq Description Document Type Size
1 LINDBLOM F4 rrd423372.html 4  
1 LINDBLOM F4 rrd423372.xml 4 3869
  Complete submission text file 0001181431-15-004448.txt   5413
Mailing Address C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Lindblom Christopher M (Reporting) CIK: 0001378796 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36072 | Film No.: 15690477

Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations